Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with liver involvement

Yaniv Berger, Samantha Aycart, Parissa Tabrizian, Yahel Agmon, John Mandeli, Marina Heskel, Spiros Hiotis, Umut Sarpel, Daniel M. Labow

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


Background We examined outcomes of patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) combined with liver resection. Methods All patients undergoing CRS/HIPEC between 2007 and 2014 were retrospectively reviewed: patients who underwent synchronous liver resection (group 1) were compared with those who did not (group 2) in terms of perioperative and long-term results. Results Group 1 included 103 patients with colorectal cancer (CRC, n = 28), appendiceal cancer (n = 34), and other malignancies. Compared with group 2 (n = 166), group 1 had higher number of organs resected, increased intraoperative blood loss, and longer hospital stay (all P ≤ 0.004) but similar major morbidity (24.3% vs. 18.1%, P = 0.22) and perioperative mortality rates. Two patients from group 1 developed liver resection-related complications. A comparison between patients who underwent parenchymal liver resection (n = 42) and matched pairs from group 2 with similar extent of cytoreduction did not yield significant differences in morbidity/mortality. CRC patients from group 1 had poorer median overall survival (45.1 vs. 73.5 months from stage IV diagnosis, P = 0.009). Conclusions Liver involvement denotes high peritoneal carcinomatosis burden, which often requires resection of multiple organs in order to achieve optimal cytoreduction. However, liver resection-related morbidity is low and overall morbidity/mortality rates are comparable to other extensive CRS/HIPEC procedures.

Original languageEnglish
Pages (from-to)432-437
Number of pages6
JournalJournal of Surgical Oncology
Issue number4
StatePublished - 15 Mar 2016


  • cytoreductive surgery
  • hepatectomy
  • hyperthermic intraperitoneal chemotherapy
  • liver resection


Dive into the research topics of 'Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with liver involvement'. Together they form a unique fingerprint.

Cite this